Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.938059
Abstract: Objective To propose a new definition of partial remission (PR) for patients with type 1 diabetes (T1D) of all-ages using insulin dose and glycated albumin (GA), and find the optimal cut-off values for stimulated C-peptide… read more here.
Keywords: age; glycated albumin; insulin dose; stimulated peptide ... See more keywords
Is Non-Stimulated C-Peptide at Diagnosis a Good Predictive Value for Insulin Use at Two Years after Diagnosis in Pediatric Diabetic Patients?
Sign Up to like & getrecommendations! Published in 2021 at "Medicina"
DOI: 10.3390/medicina57090902
Abstract: Background and Objectives: Insulin treatment may be initially required to stabilize patients presenting with metabolic crisis at type 1 and 2 diabetes mellitus (DM) onset. Some patients with type 2 DM may need persistent insulin… read more here.
Keywords: insulin use; insulin; years diagnosis; two years ... See more keywords